A recent analysis indicates that over 5% of women who took mifepristone for abortion required a second procedure within 45 days, highlighting potential issues with the pill's effectiveness.
The Illinois House of Representatives, led by Democrats, has passed House Bill 3637, aiming to ensure continued access to abortion medication, specifically mifepristone, regardless of potential federal restrictions.
